M42, the global tech-enabled health company based in Abu Dhabi, has announced the launch of the M42 Microbiome Wellness Program.
Exclusively at M42, this initiative combines advanced DNA sequencing technology with personalised consultations.
The program is available at Mubadala Health Dubai and is set to be launched at other M42 assets, including Healthpoint in the future.
Speaking about the importance of the microbiome, Dr Pranab Gyawali, said: “It’s truly a new, exciting frontier that not many people are aware of. In a nutshell, the microbiome comprises the diverse community of bacteria, viruses and fungi residing within the intestine. These microorganisms, along with the metabolites they produce, play a crucial role in various bodily functions such as immunity, digestion and brain functioning. We now recognize the significance of these products in contributing to and enhancing the overall well-being of the body.”
The program, featuring the advanced shotgun metagenomic sequencing technology, provides quick turnaround times and is licensed by the Ministry of Health and Prevention, with the test generating a comprehensive 60-page report, providing insights for personalised recommendations by healthcare professionals.
It offers tailored solutions for diverse health goals, from addressing gut issues to enhancing sports performance, weight management and diabetes management.
It was noted that the program also has potential in sports performance by targeting specific gut bacteria that enhance athletic abilities through lactic acid metabolism and muscle recovery promotion.
Further, M42 shared that beyond digestion and immunity, ongoing research explores links between the microbiome and conditions like autoimmune diseases and neurodegenerative disorders.